Secretory fibroblast growth factors (FGFs) and their receptors are known for their regulatory function in the early stages of neural development. FGF13, a nonsecretory protein of the FGF family, is expressed in cerebral cortical neurons during development and is a candidate gene for syndromal and nonspecific forms of X-chromosome-linked mental retardation (XLMR). However, its function during development remains unclear. We show that FGF13 acts intracellularly as a microtubule-stabilizing protein required for axon and leading process development and neuronal migration in the cerebral cortex. FGF13 is enriched in axonal growth cones and interacts directly with microtubules. Furthermore, FGF13 polymerizes tubulins and stabilizes microtubules. The loss of FGF13 impairs neuronal polarization and increases the branching of axons and leading processes. Genetic deletion of FGF13 in mice results in neuronal migration defects in both the neocortex and the hippocampus. FGF13-deficient mice also exhibit weakened learning and memory, which is correlated to XLMR patients' intellectual disability.
INTRODUCTION
Brain function and plasticity rely on the complex architecture of neural circuits that are established during development. Defects in neuronal morphogenesis, cell migration, and synaptogenesis in the cerebral cortex can lead to mental retardation, autism spectrum disorders, and epilepsy (Kerjan and Gleeson, 2007; Ramocki and Zoghbi, 2008; Walsh and Engle, 2010) . X-linked mental retardation (XLMR) is an inherited intellectual disability with disordered neural development. Interestingly, fibroblast growth factor 13 (FGF13), a member of the FGF homologous factor (FHF) subfamily, is a candidate gene for the syndromal and nonspecific forms of XLMR mapped to the q26 region of the X chromosome (Gé cz et al., 1999; Goldfarb, 2005; Malmgren et al., 1993) . FGF13 is widely distributed in the developing brain, with an expression level $5-fold higher than other FHF members, such as FGF11, 12, and 14 (Smallwood et al., 1996) . Although FGF13 might be involved in neural differentiation in early development of Xenopus (Nishimoto and Nishida, 2007) , the FGF13 function during brain development remains largely unknown.
Members of the FHF subfamily are expressed in the cerebral cortical neurons in the developing brain (Goldfarb, 2005; Hartung et al., 1997; Smallwood et al., 1996) . FGF14-deficient mice develop ataxia and a paroxysmal hyperkinetic movement disorder (Goldfarb et al., 2007; Wang et al., 2002) . Fgf12 knockout mice also display muscle weakness (Goldfarb, 2005) . However, histological abnormalities have not been detected in the nervous system of these mice. Given that FGF13 is widely expressed in the developing brain and may be associated with XLMR, we hypothesize that the loss of FGF13 might result in neuronal malformation of the cerebral cortex and intellectual disability. Moreover, FGF2, one of the secretory FGFs (FGF1-10 and FGF15-23) that contain an N-terminal signal peptide (SP) for secretion and function via their receptors, has been found to enhance axonal branch formation by augmenting the severing of microtubules (MTs) (Qiang et al., 2010) . However, FGF13 lacks an SP and thus may function intracellularly (Goldfarb, 2005) . Therefore, we sought to determine whether FGF13 might contribute to the intracellular regulatory mechanisms that coordinate neuronal development.
Proper regulation of MT dynamics during axon/leading process formation is crucial for the transition of neurons from the multipolar stage to a bipolar morphology, which is a prerequisite for initiating radial migration (Jaglin and Chelly, 2009; . Tubulins and a number of MT-regulating proteins that promote MT assembly or protect MTs from depolymerization, such as MT-stabilizing proteins (MSPs), are involved in this regulatory process (Poulain and Sobel, 2010) . During the multipolar stage, the local stabilization of MTs is required for the induction of axonal formation through the extension of one neurite among many other neurites that are being retracted (Stiess and Bradke, 2011; . Several members of the MSP family, such as classical MT-associated proteins (MAPs) and doublecortin (DCX), are essential for the early phase of neuronal migration (Bai et al., 2003; Teng et al., 2001 ). These molecules have distinct binding sites on MTs, different actions on nucleation and dynamics, and various expression patterns during development. The loss of MAP1B or DCX results in an increase in axon/leading process branching (Bouquet et al., 2004; Kappeler et al., 2006) . Axon tract abnormalities and defects in cortical lamination were found in the brains of MAP1B-and Tau-deficient mice (Takei et al., 2000) . A reduction in DCX leads to an accumulation of multipolar neurons in the intermediate zone (IZ) of the cortex (Bai et al., 2003; Koizumi et al., 2006) , which resembles the formation of subcortical laminar heterotopias observed in human patients (Gleeson et al., 1998) . Thus, MSPs are directly linked to MT dynamics, axon formation, and neuronal migration.
In this study, FGF13 was identified as an MSP enriched in the growth cones of cortical neurons. Neuronal migration was delayed, and severe mental retardation was found in Fgf13 knockout mice, indicating an essential role of FGF13 in establishing neural circuits in the cerebral cortex and enabling cognitive functions.
RESULTS

FGF13 Is Expressed in the Developing Cerebral Cortex
Using real-time PCR, we found that FGF13 mRNA levels in the mouse cerebral cortex gradually increased from embryonic day 14 (E14) until postnatal day 7 (P7), after which levels began to decrease ( Figure 1A ). Two alternative splicing isoforms of FGF13 have been identified: FGF13A, which contains a nuclear localization signal (NLS), and cytoplasmic FGF13B without an NLS (Schoorlemmer and Goldfarb, 2001; Smallwood et al., 1996) . We therefore measured the abundance of FGF13B in the developing cerebral cortex and found that high levels of FGF13B mRNA and protein were transiently present in the neocortex and hippocampus from E17 to P7 ( Figures 1A and 1B) .
In the developing brains of mice, FGF13 mRNA was present in the subplate (SP), ganglionic eminences (GE), and proliferative zones of the cortical wall (the ventricular zone [VZ] and the subventricular zone [SVZ] ) at E14 and in the cortical plate (CP) of the cerebral cortex, hippocampus, and striatum from E17 to P14 ( Figure 1C and Figures S1A-S1E available online). However, FGF13 expression was markedly reduced in the brains of adult mice ( Figure S1F ). Intensive FGF13 immunostaining was found in the SP of the embryonic cortex and the axonal tracts in the IZ ( Figures 1D and S1G ). FGF13 was also found in axonal tracts of projection neurons, specifically in the corticothalamic tract and the corpus callosum ( Figure S1H ). Colocalization of FGF13 with DCX was observed in the SP and the axonal tracts but gradually reduced from the CP to the marginal zone (MZ) that contained DCX-positive dendrites, consistent with the finding that the FGF13 level in the dendrites was relatively lower than DCX in cultured cortical neurons ( Figures S1I and S1J) . A similar pattern of FGF13 expression existed in rats (data not shown). Furthermore, FGF13A was localized in the nucleus of cortical neurons, whereas FGF13B was distributed in the cytoplasm ( Figure S1K ).
FGF13 Is Associated with MTs in Growth Cones
Neurons cultured from rat hippocampus extend several neurites during the first 12-24 hr following plating (stages 1-2). One of the neurites then begins to extend rapidly and form an axon (stage 3). Finally, during stage 4, the remaining neurites acquire the morphological features of dendrites (Craig and Banker, 1994) . During stages 1 and 2, FGF13 was localized in the cytoplasm, filopodias, and neurites of cultured neurons ( Figure 1E ). After the establishment of neuronal polarity, FGF13 accumulated in the growth cones of axons (Figures 1E and 1F) and colocalized with MTs but did not invade into lamellae and filopodia labeled by phalloidin-fluorescein isothiocyanate (FITC) ( Figure 1G ). FGF13 may associate with MTs because colocalization was maintained in the growth cones after a treatment with a fixative containing 1% Triton X-100, which permeabilizes the plasma membrane and removes soluble proteins ( Figure 1G ). Moreover, FGF2 and FGF7, but not FGF13, were secreted into the culture medium ( Figure 1H ), supporting the idea that FGF13 is a cytoplasmic protein.
FGF13 Interacts with Tubulin
To determine whether FGF13 interacted with MTs, sedimentation experiments using rat brain extracts were performed. After successive cycles of tubulin polymerization, FGF13B cosedimented in the same fraction as DCX with the newly formed, stabilized MTs; however, FGF2 was enriched in the supernatant and was not bound to MTs (Figure 2A ). Coimmunoprecipitation (Co-IP) showed that FGF13B and DCX interacted with b-tubulin ( Figure 2B ). Glutathione S-transferase (GST) pull-down assay showed that FGF13B could bind to tubulin directly ( Figures 2C  and 2D ). (A) Sedimentation analysis with the rat brain extract shows that FGF13 is reversibly associated with MTs throughout the polymerization and depolymerization cycles. FGF13 and DCX were found in both the soluble (S0) and insoluble (P0) fractions. Tubulins in S0 were polymerized to form MTs and sedimented, resulting in S1 and P1 fractions. The MTs in P1 were incubated at 0 C for 1 hr and resedimented (S1 0 and P1 0 ). The S1 0 fraction was subjected to a further cycle of polymerization followed by sedimentation (S2, P2). Both FGF13 and DCX were associated with newly polymerized MTs. (B) Co-IP shows that FGF13 and DCX coprecipitate with tubulin in brain lysates.
(C) Schematic diagrams of secretory FGFs, FGF13A and B, and FGF13B mutants. SP, signal peptide. NLS, nuclear localization signal.
(D and E) GST pull-down assay shows that FGF13B binds to tubulin and that the S104-Q111 sequence is a tubulin-binding domain (TBD) (D). FGF7 does not bind to tubulin, whereas the FGF7 mutant, with a substitution of FGF13B TBD for the S153-S159 sequence of FGF7, interacts with tubulin (E). Equal amounts of GSTfused proteins were subjected to electrophoresis on a native gel, followed by Coomassie brilliant blue staining.
To identify the potential domain of FGF13 responsible for the interaction with tubulin, we made a series of GST-tagged deletion (D) mutants of FGF13B ( Figures S2A-S2E ). GST pull-down assay showed that FGF13B DT101-G115 did not bind to tubulin ( Figures S2C-S2E ), suggesting that it contains the amino acid residues required for the interaction with tubulin. Sequence alignments showed that FGF13B T101-G115 is not conserved in the secretory FGFs, such as FGF7, that did not bind to tubulin ( Figures 2E and S2A ). To test whether FGF13B T101-G115 contained a tubulin-binding domain (TBD), we performed an in vitro association assay with a series of GST-tagged FGF13B mutants (M1-9) ( Figures 2C, 2D , S2B, and S2F-S2I). The M3 mutant, FGF13B S104-Q111/104A-111A , was found to have a disrupted interaction with tubulin ( Figures 2D and S2E-S2H) . Furthermore, the FGF7 mutant with FGF13B S104-Q111 substitution for FGF7 S153-S159 could bind to tubulin ( Figures 2E, S2A , and S2I).
Thus, FGF13B S104-Q111 is the TBD ( Figure S2J ) that mediates the FGF13 binding to tubulin.
FGF13 Induces MT Polymerization and Stabilization
Next, we examined whether FGF13 could affect MT formation with an absorbance-based tubulin polymerization assay. The reaction was initiated by adding GST-FGF13B into a solution containing purified tubulins and GTP. The turbidimetric assay showed that FGF13B dose-dependently enhanced MT polymerization ( Figure 2F) ; however, FGF13B M3 with a mutated TBD could not polymerize MTs ( Figure 2G ). Moreover, rhodamine-labeled tubulins could be assembled into an MT network in the presence of FGF13B, but not FGF13B M3 ( Figure 2H ). Thus, FGF13B indeed induces MT polymerization.
To test whether FGF13 can stabilize MTs, we expressed myc-tagged FGF13B in NIH 3T3 fibroblasts. These cells were then immunostained for acetylated (Ace) or tyrosinated (Tyr) tubulins, which are markers for stable and dynamic MTs, respectively. Ace-MTs were bundled to give a whorl-like appearance in the fibroblasts transfected with the plasmid expressing FGF13B, but not in the cells expressing FGF13B M3 ( Figure 2I ). However, the diffuse distribution of Tyr-tubulins was not altered by FGF13B ( Figure 2I ). Moreover, we isolated the fractions of insoluble and soluble MTs from HEK293 cells that stably expressed either FGF13B or FGF13B M3 at time points before or after treatment with nocodazole, an MT destabilizer. Immunoblotting showed that FGF13B, but not FGF13B M3, increased the amount of Ace-tubulin in the insoluble fraction of tubulins and protected MTs from nocodazole-induced depolymerization ( Figure 2J ). Therefore, FGF13 not only binds to tubulins but also polymerizes and stabilizes MTs.
FGF13 Is Required for MT Polymerization and Stabilization in Neurons
To examine the FGF13 function in neuron morphogenesis and brain development, FGF13 expression was silenced in cortical neurons by electroporating short-hairpin-interfering RNAs (shRNAs; Figures S3A-S3D ). FGF13 was also deleted in the cerebral cortex by crossing homozygous Fgf13-floxp mice with Emx1-Cre (cerebral-cortex-specific knockout) or EIIa-Cre mice ( Figures S3E-S3I ).
To test whether FGF13 loss impaired MT assembly in neurons, a high-intensity laser was used to photobleach the distal axons of red fluorescent protein (RFP)-a-tubulin-expressing cortical neurons, and then the recovery of RFP-a-tubulin into the bleached region was measured ( Figure 3A ). Cultured cortical neurons were transfected with plasmids expressing either shRNA-4 (targeting FGF13 mRNA) or the negative control (shNC) for 4 days ( Figures S3A-S3C ). Notably, silencing FGF13 in cortical neurons attenuated the recovery of assembled RFPa-tubulins ( Figures 3A and 3B ), suggesting that FGF13 is required for the assembly of MTs in neurons.
Immunoblotting showed that tubulin acetylation was reduced in the brain lysates of Fgf13 knockout mice (EIIa-Cre/ Figure 3D ). In contrast, the MT bundle was disrupted and formed multiple branches and comets in the growth cones of cortical neurons cultured from Fgf13 knockout mice ( Figures 3D-3F ). Thus, FGF13 is required for stabilizing MT organization in the growth cone.
FGF13 Regulates Axonal Formation and Refinement
To examine FGF13 function during neuronal development, we transfected cortical neurons with FGF13 shRNA constructs ( Figures S3A-S3D ) and analyzed the neuronal morphology 4 days later. Most of the control neurons developed a unique axon and several dendrites immunostained for Tau and MAP2, respectively ( Figure S4A ), whereas $50% of the FGF13 shRNA-expressing neurons did not develop into polarized neurons ( Figures 4A and 4B ). The neurites of nonpolarized neurons often contained both Tau and MAP2 ( Figure S4A ). The remaining neurons had a unique axon with aberrantly elongated axonal branches that split further into tertiary and quaternary sections. The total number of dendritic branches was also (F) FGF13B increases the rate and amount of tubulin (1 mg/ml) polymerization to form MTs in the presence of 1 mM GTP. The degree of polymerization, as measured by turbidity, was recorded over 500 s (n = 3 each trace).
(G) Turbidimetric assay shows that the FGF13B-induced tubulin polymerization is abolished by TBD mutation (M3) (n = 3 each trace). increased ( Figures 4A and 4B) . Furthermore, the abnormal axon formation and branching of FGF13-deficient neurons were reversed by the addition of either shRNA-resistant (R) FGF13B (FGF13B R ; Figure S3A ) or DCX, but not FGF13B M3 R (Figure 4B) . FGF13A was not involved in neuronal polarization, although it shared an overlapping function with FGF13B in regulating axonal branching ( Figure 4B ). These data suggest that FGF13 controls axon development through MT stabilization.
Cortical neurons were cultured from wild-type and Fgf13 knockout mice for 3 days and then stained with b-III tubulin antibodies. Most neurons from Fgf13 F/F & F/Y mice extended a single primary axon ( Figure 4C ). However, nearly half of the FGF13-deficient neurons remained as a multipolar shape, whereas the other half had a polarized shape with an overextension of axonal branches ( Figure 4C ). The polarization was reinstated in the FGF13-deficient neurons by re-expressing FGF13B, but not FGF13B M3 ( Figure 4C ). Using in utero electroporation, we found that the complexity of axonal arbors of FGF13 shRNA-expressing cortical neurons was increased at P7 ( Figure S4B ). Tracing the axonal bundle of layer II-III projection neurons in the somatosensory cortex and the corticothalamic tract with DiI showed that axonal branching was increased in Emx1-Cre/Fgf13 F/Y mice ( Figures S4C and   S4D ). These results suggest that the cortical structure and neural circuits are disorganized in the mutant mice. Thus, FGF13 is required for the formation and structural refinement of axons.
FGF13 Controls Neuronal Polarization and Migration
To test whether FGF13 loss affected cortical development, in utero electroporation was used to cotransfect radial glial progenitors in the cerebral cortex of E15.5 rats with a plasmid coexpressing FGF13 shRNA and GFP as a marker. The distribution of GFP-positive cells in the cortical wall, which is divided into layers I, II-III, IV-VI, and VZ/SVZ/WM, was examined at P0. Approximately 75% of the FGF13 shRNA-expressing neurons were multipolar and remained in the white matter (WM) zone, whereas the control cortical neurons migrated into layers II-VI and often had a bipolar shape ( Figure 4D ). FGF13-deficient bipolar neurons migrated into layers IV-VI and developed highly branched leading processes ( Figure 4E ). Moreover, FGF13 was deleted in cortical neurons by electroporating Cre recombinase into the brains of Fgf13 F/F mice at E14.5. Most FGF13-deficient neurons were positioned in the WM zone with a multipolar shape ( Figure 4F ). Thus, FGF13 is required for the polarization and the development of leading processes of cortical neurons. We also found that the number of FGF13-silenced neurons that reached layers II-III was reduced in rats at P7 and P14, whereas the number of neurons that remained in the WM and layers IV-VI was increased ( Figures 5A and 5B) . Similarly, when FGF13 was deleted in cortical neurons by electroporating Cre recombinase into the brains of Fgf13 F/F mice at E14.5, a migration defect was found in cortical neurons at E18 and P0 ( Figures 5C  and 5D ). Labeling of early-born cortical neurons at E14 with bromodeoxyuridine (BrdU) showed that a considerable proportion of neurons remained in layers V-VI of FGF13-deficient mice at P0 ( Figures S4E and S4F ). The migratory defect could be rescued by the addition of FGF13B R , but not FGF13A R ( Figures  5A and 5B) , which is consistent with the finding that silencing FGF13A had no effect on neuronal migration ( Figures S3A-S3C and S5A-S5C). The neuronal polarization and migration in wildtype mice were not apparently modified by overexpressing FGF13 (Figures S5D-S5F ). To test whether the neuronal malformations in positioning could be rescued by reversing the disruption of the MT network, we coexpressed FGF13 shRNA and FGF13B M3 R or DCX in the embryonic cortex. We found that DCX, but not FGF13B M3 R , could rescue the abnormal migration induced by FGF13 deficiency (Figures 5E and 5F ). Overexpression of FGF13B also rescued the migratory defect caused by loss of DCX ( Figure 5F ). Thus, FGF13 controls neuronal migration by regulating MT dynamics.
FGF13 Regulates the Laminar Development of the Cerebral Cortex
To study laminar defects in the cerebral cortex, brain sections of Emx1-Cre/Fgf13 F/Y and EIIa-Cre/Fgf13 F/Y mice were stained with Cux1 or Tbr1 antibodies, which label neurons in the superficial (II-IV) or deep layer (V-VI), respectively. In the cortex of mutant mice at E14-16, the pattern of radial glial scaffold, neural stem cell pool, and Tbr1-positive early-born neurons was not apparently changed ( Figures S6A-S6C ). Cell proliferation and apoptosis were not affected by genetic manipulation of Fgf13 (Figures S6D-S6I) . However, many Cux1-positive neurons were mislocated in the deep layers of the lateral somatosensory cortex of FGF13-deficient mice at E18 (Figures 6A and 6C) . Although many Cux1-positive neurons were found in cortical layers II-IV of FGF13 null mice at P0, they were also scattered throughout layers V-VI, and the thickness of the superficial layer was reduced ( Figures 6B, 6C , and S6J). The cell density of Tbr1-positive neurons in the deep layer was subtly increased, corresponding to the reduced number of Cux1-positive cells ( Figure 6D ). Thus, the laminar formation of neocortex is delayed in the absence of FGF13 ( Figure 6E ). At P14 and adulthood, the positioning of Cux1-positive neurons in the neocortex of mutant mice became similar to that in control mice (Figures S6K and S6L) . Hippocampal formation in FGF13-deficient mice was also abnormal. Both the cornu ammonis (CA) fields and the dentate gyrus (DG) were disorganized in the mutant mice at P7. The pyramidal layer of CA1 was split, with heterotopic neurons in the stratum oriens on the up-side of the pyramidal layer ( Figures  6F and 6G) . Moreover, the pyramidal layer of CA1 had more loosely arrayed neurons with irregular inner and outer borders ( Figures 6F1 and 6F1 0 ). Importantly, the granule cell layer in the DG was disrupted with loosely packed neurons ( Figure 6F ). The number of neurons positioned in the polymorphic layer of the DG was increased ( Figure 6G ). The positioning of hippocampal neurons in the mutant mice at P30 became similar to the control. Therefore, FGF13 expression is critical for hippocampal development.
Learning and Memory Are Impaired in FGF13-Deficient Mice
We used the Morris water maze to test the learning and memory of mice. Most control littermate mice learned to use distal cues to navigate a direct path to the hidden platform following a 5 day training period. However, Emx1-Cre/Fgf13 F/Y mice showed an increased escape latency during the training process and a reduced time spent in the target quadrant ( Figure 7A ). In the probe test to assess spatial memory, the mutant mice did not show a preference for the target quadrant, whereas control mice spent more time in the target quadrant ( Figures 7B and  7C) . However, the swimming speed of the mutant mice was not changed ( Figure 7D ). EIIa-Cre/Fgf13 F/Y mice also exhibited a similar deficiency of spatial acquisition and memory ( Figures  S7A-S7D) . Moreover, the cued memory and the capacity of novel object recognition were impaired in the mutant mice ( Figures 7E and 7F) . Thus, learning and memory are impaired in FGF13-deficient mice. FGF13-deficient mice did not show any apparent motor disability ( Figure 7G ). However, Emx1-Cre/Fgf13 F/Y mice had a slight increase in spontaneous activity ( Figure S7E ). The mutant mice also displayed anxiety-related behavior and reduced depression-like behavior, but social interaction remained normal ( Figures S7F-S7K ). Thus, FGF13-deficient mice may have mood disorders.
DISCUSSION
FGF13 Acts as an MSP during Brain Development
Neuronal polarization occurs when cortical neurons start the radial migration. MT dynamics contribute to the cytoskeletal reorganization that underlies growth cone guidance, axon branching, cell polarization, and neuron migration (Kalil et al., 2000; Poulain and Sobel, 2010; Valiente and Marín, 2010) . MTs are polarized cytoskeletal polymers that undergo rapid cycles of polymerization and depolymerization, with a/b-tubulin dimers being preferentially added to the plus end and removed from the minus end. MT stabilization allows MTs to protrude with their dynamic ends more distally, thereby promoting axon formation. Axonal fate of a neurite could be determined by locally applied MT stabilizer . Loss of DCX attenuates neuronal polarization (Koizumi et al., 2006) . Stathmin family protein SCG10 destabilizes the minus end of MTs to provide soluble tubulin for net plus end elongation (Manna et al., 2007) . Multipolar stage exit and neuronal migration rate could be increased by either destabilizing the minus end via reducing SCG10 phosphorylation or stabilizing the plus end via reducing DCX phosphorylation (Gdalyahu et al., 2004; Westerlund et al., 2011) . Thus, MT dynamics is regulated spatially and temporally by a number of molecules (Poulain and Sobel, 2010) . Secretory FGFs are best known for their role in the regulation of early stages of neural development, such as the patterning of the neural primordium and the proliferation of neural progenitors (Guillemot and Zimmer, 2011) . We provide several lines of evidence showing FGF13 as an MSP. First, FGF13 colocalized with MTs in the growth cone. Second, FGF13 interacted directly with tubulin via a TBD. Third, FGF13 could polymerize MTs in vitro. Finally, ectopic expression of FGF13 increased the acetylation of tubulin and stabilized MTs, even after nocodazole treatment. Thus, FGF13 has the general properties of an MSP. It has been proposed that branching from the growth cone and the axonal shaft is preceded by a splaying of looped or bundled MTs and an accumulation of F-actin (Dent et al., 1999; Kalil et al., 2000) . Loss of FGF13 in the growth cone may increase the amount of unstabilized and short MT filaments that could invade into the edge of growth cone. The reorganization of these dynamic MTs in the growth cone may initiate and elongate axonal branches ( Figure 7H ).
Requirement of FGF13 for Neuronal Polarization and Migration
The MT network that surrounds the nucleus and connects to the centrosome provides pulling forces for the directed migration of neurons (Tsai and Gleeson, 2005) . However, most perinuclear MTs are not anchored to the centrosome but instead extend into the leading process (Umeshima et al., 2007) . MTs play an active role in axonal specification, the end of the multipolar stage, and the early phase of neuronal migration (Jaglin and Chelly, 2009; LoTurco and Bai, 2006; . Increased MT stabilization induces the formation of a single axon from multipolar cortical neurons . The disruption of MT stabilization impairs the transition out of the multipolar stage during migration (LoTurco and Bai, 2006) . Defects in axonal morphogenesis and neuronal migration occur in Map1b/Mapt double-knockout mice (Gonzalez-Billault et al., 2001; Takei et al., 2000) . We found that most FGF13-deficient neurons were stalled at the multipolar stage and had migration defects, which is consistent with an MT-stabilizing function of FGF13. Thus, the FGF13/MT interaction is essential for regulating neuronal polarization and migration ( Figure 7I ).
In the late phase of neuronal migration, cortical neurons transform into a bipolar shape with a leading process in the upper IZ that moves toward the superficial CP. The tip of the leading process pulls soma forward during neuronal migration (He et al., 2010 ). An increase in leading process branching may slow the migration rate (Lysko et al., 2011) . Axon/leading process branching involves the reorganization of the MT array into a more mobile form, in which MTs can become debundled and fragmented (Kalil et al., 2000) . At present, the role of MT destabilization in promoting or suppressing branching remains controversial (Kornack and Giger, 2005; Poulain and Sobel, 2010) . MAP1B-, Tau-, or DCX-deficient neurons have highly branched axons and leading processes (Bouquet et al., 2004; Kappeler et al., 2006) . We found that the leading processes of FGF13-deficient neurons had overextended branches that might delay the late phase of migration. Interestingly, FGF13 and DCX may function independently during neural development because the inhibition of neuronal migration by either DCX shRNA or FGF13 shRNA could be rescued by overexpressing FGF13 or DCX, respectively. Thus, FGF13 contributes to different phases of migration by controlling both the initiation and refinement of leading processes.
FGF13-Deficient Mice as a Potential Animal Model for XLMR
The importance of cytoskeleton components in the cellular processes that are crucial for cortical development has emerged from several functional analyses (Keays et al., 2007; Poulain and Sobel, 2010; Valiente and Marín, 2010) and has been reinforced by the association of Dcx mutations with developmental disorders of the cortical system (Corbo et al., 2002; Kappeler et al., 2006; LoTurco and Bai, 2006) . Dcx mutations in humans cause lissencephaly and double-cortex phenotype (Gleeson et al., 1998) . DCX deletion in mice results in defects in axonal branching and hippocampus lamination that are associated with impaired learning, but it does not disrupt neocortical neuron migration and lamination (Corbo et al., 2002) . A double knockout of Dcx and the gene encoding DCX-like kinase causes neocortical lamination deficits (Deuel et al., 2006) . We found that FGF13 loss delayed neuron migration in both the neocortex and hippocampus and also impaired learning and memory. Notably, the cortical disorganization in Fgf13 knockout mice was not fully rescued by endogenous DCX. This may be due to the differential distribution of FGF13 and DCX in cortical zones and a possibility that the molecular mechanism of FGF13 in MT regulation differs from that of DCX (Moores et al., 2004) .
Duplication in Xq26 may contribute to XLMR (Gé cz et al., 1999 (Gé cz et al., , 2009 Solomon et al., 2002) . Duplication may disrupt the coding or regulatory region of the gene located at the boundaries of the duplicated region or may induce a dosage effect of proteins encoded by genes located within the duplicated region. Fgf13 may be interrupted by a duplication breakpoint in a Bö rjesonForssman-Lehmann-syndrome-like patient (Gé cz et al., 1999) . Our findings support the idea that the duplication-induced interruption of Fgf13 may cause diseases. The correlation between the behavior abnormalities of Fgf13 knockout mice and the developmental delay in the patients suggests that FGF13-deficient mice may serve as a relevant animal model for a fraction of Xq26-associated XLMR syndrome.
The impaired learning and memory of FGF13-deficient mice could be attributed to the delayed neuronal migration and increased collateral branching of axons, which could disrupt the establishment of neural circuits. The abnormal neural circuits formed during development may remain in the adult brain of the mutant mice, although the positioning of cortical neurons becomes similar to that of normal mice. Moreover, the synaptogenesis, action potential firing, and synaptic transmission might be affected by Fgf13 deletion because FHFs may regulate neuronal excitability through interacting with voltage-gated sodium channels (Goldfarb et al., 2007; Wittmack et al., 2004) . Future analysis of FGF13-deficient mice will help to understand the XLMR-related mechanisms.
EXPERIMENTAL PROCEDURES
Real-Time PCR Total mRNAs of the neocortex and the hippocampus of E14, E17, P0, P7, P14, P28, and P60 mice were extracted with TRIzol reagent (Invitrogene). SuperScript II reverse transcriptase (Invitorgene) was used for reverse transcription to produce complementary DNAs (cDNAs). Real-time PCR was performed with the SYBR Premix Ex Taq (Takara) and on an ABI Prism 7500 apparatus. Primer pairs are listed in Table S1 .
In Situ Hybridization and Immunoblotting
The details are provided in the Extended Experimental Procedures and Table S1 .
Immunostaining
Cryostat sections of brains were immunostained. For growth cone staining, cultured neurons were fixed with 2% glutaraldehyde in PHEM buffer for 15 min. For permeabilized labeling, 1% Triton X-100 was added to the fixative to remove the membrane and soluble substances, leaving cytoskeletal components and their associated proteins. See Extended Experimental Procedures for details.
Targeting of Fgf13 Locus and Generation of FGF13-Deficient Mice
To investigate functions of FGF13 in the central nervous system (CNS), we employed a strategy of conditional deletion of the FGF13 gene (located in the X chromosome) in mice ( Figure S3E ). The exon 2 and 3 encoding the core region of FGF13 was flanked with two loxP sequences. Detailed procedure is provided in Extended Experimental Procedures. The wild-type, heterozygous, and homozygous Fgf13-floxp mice were identified by PCR amplification ( Figure S3F ). The loxP sites did not interfere with the normal expression of the gene but constitute a binding domain for the DNA recombinase Cre. Thus, the deletion of Fgf13 in the prefrontal cortex could be triggered in vivo by crossing the floxP mice with transgenic animals expressing Emx1-Cre or EIIa-Cre. Immunoblot analysis of prefrontal cortical extracts of littermates homozygous for the Fgf13-floxp allele with expression of Cre demonstrated a significant reduction of FGF13 expression ( Figure S3G ). Immunostaining of coronal sections of the cerebral cortex at P0 substantiated the absence of FGF13 in the cortical neurons and corpus callosum ( Figure S3H ). Co-IP and GST Pull-Down Assays Brain extracts were processed for immunoprecipitation (IP) and immunoblotting. For GST pull-down assay, purified tubulins were mixed with GST-FGF13B or a series of GST-FGF13B mutant proteins. The protein complex was then precipitated by glutathione sepharose beads. See Extended Experimental Procedures for details.
Tubulin Polymerization Assay
The tubulin-polymerizing activity of FGF13 and its mutants was determined by measuring the kinetics of optical density using a Tubulin Polymerization Assay Kit (Cytoskeleton Inc). For rhodamine-tubulin experiments, purified GSTrecombinant proteins or GST control proteins were mixed with rhodaminetubulin in a tubulin glycerol buffer, spread on microscope slides, and observed under the microscope (see Extended Experimental Procedures).
Fluorescence Recovery after Photobleaching
Embryonic hippocampal neurons were cotransfected with tubulin-RFP and control shRNA or FGF13 shRNA4 and then imaged under a laser-scanning microscope 48 hr after transfection. Distal axons were photobleached, and the recovery of tubulin fluorescence was monitored (see Extended Experimental Procedures).
Cell Culture, Transfection, and In Utero Electroporation The methods are provided in Extended Experimental Procedures.
Behavior Tests Morris Water Maze Test
Standard procedure of Morris water maze test was used (Vorhees and Williams, 2006) . Male adult mice (10-12 weeks old) from each genotype were trained to find the visible platform with four trials a day for the first day and tested to find the hidden platform for 5 to 6 consecutive days. In each trial, mice were allowed to swim until they found the hidden platform when starting from different, random locations around the perimeter of the tank. Mice were then allowed to sit on the platform for 10 s before being picked up. During the probe trial day, the platform was removed from the tank. The escape latency and the time spent in each quadrant were recorded by a video camera. The experimenter was blind to the genotypes and ages of the mice.
Fear Conditioning Tests
For contextual and cued memory tests, two rounds of training were performed. Each round consisted of a 2 min exposure of mice to the conditioning box (context), followed by a cued tone (30 s, 300 Hz, 90 dB sound) and a foot shock (2 s, 0.75 mA constant current) (Wehner and Radcliffe, 2004) . The short-time contextual memory test was performed 3 hr later by re-exposing the mice for 6 min to the conditioning context (Guan et al., 2009) . The cued memory test was performed 24 hr later by exposing the mice for 3 min to a novel context, followed by an additional 3 min exposure to a cued tone.
Novel Object Recognition Test
Male adult mice were placed in an open field to get familiar with two identical objects for 15 min. To test for object recognition after the training-to-test interval (1 hr), one of the objects was then replaced with a novel object and the animals were exposed in the apparatus again to measure the time spent on exploring each of the objects (Bevins and Besheer, 2006 
